サマリー

欧州の臨床検査サービス市場は、2023年から2030年の予測期間に6.5%の大幅なCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年で、予測期間は2023年から2030年です。
市場区分
欧州臨床検査サービス：専門分野別（臨床化学検査、血液学検査、微生物学検査、免疫学検査、乱用薬物検査、解剖病理学サービス、遺伝子検査、その他エソテリック検査）、技術別（化学発光免疫測定、酵素結合免疫吸着測定、質量分析、リアルタイムPCR、DNAシークエンス、フローサイトメトリ、その他技術）、プロバイダー（独立研究所、リファレンスラボ、用途（創薬関連サービス、開発関連サービス、バイオ分析・ラボ化学サービス、毒性試験サービス、細胞・遺伝子治療関連サービス、前臨床・治験関連サービス、その他臨床検査サービス）、エンドユーザー（病院、クリニック、研究所）、国（ドイツ、フランスK.,イタリア、スペイン、ロシア、トルコ、ベルギー、オランダ、スイス、その他ヨーロッパ）産業動向と2030年までの予測。

欧州の臨床検査サービス市場の成長に寄与する主な要因としては、以下のものが挙げられます：

- 疾病の早期・正確な診断に対する需要の高まりと臨床診断法の高度化
- デジタルパソロジープラットフォームの導入が進み、臨床検査室が提供する総合的な健康診断が好まれるようになったこと。

市場関係者

欧州の臨床検査サービス市場で事業を展開する主要な市場プレイヤーを以下に紹介します：
- アボット
- クエスト・ダイアグノスティックス・インコーポレイテッド
- SYNLAB International GmbH
- ユーロフィンズサイエンティフィック
- ソニックヘルスケアリミテッド
- ダビタ・インク
- チャールズリバーラボラトリーズ
- ARUPラボラトリーズ
- セルバ・ヘルスケア

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 OVERVIEW OF THE EUROPE CLINICAL LABORATORY SERVICES MARKET 18
1.4 LIMITATIONS 20
1.5 MARKETS COVERED 20
2 MARKET SEGMENTATION 22
2.1 MARKETS COVERED 22
2.2 GEOGRAPHICAL SCOPE 23
2.3 YEARS CONSIDERED FOR THE STUDY 23
2.4 CURRENCY AND PRICING 23
2.5 DBMR TRIPOD DATA VALIDATION MODEL 24
2.6 MULTIVARIATE MODELLING 27
2.7 SPECIALTY LIFELINE CURVE 27
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 28
2.9 DBMR MARKET POSITION GRID 29
2.10 VENDOR SHARE ANALYSIS 31
2.11 SECONDARY SOURCES 32
2.12 ASSUMPTIONS 32
3 EXECUTIVE SUMMARY 33
4 PREMIUM INSIGHTS 36
4.1 PESTEL ANALYSIS 37
4.2 PORTER'S FIVE FORCES 38
4.3 INDUSTRIAL INSIGHTS 39
4.4 OVERVIEW OF ADJACENT BUSINESS 40
4.5 REIMBURSEMENT SCENARIO 42
5 EUROPE CLINICAL LABORATORY SERVICES MARKET: REGULATIONS 48
6 MARKET OVERVIEW 55
6.1 DRIVERS 57
6.1.1 RISE IN INFECTIOUS DISEASES 57
6.1.2 ADVANCEMENT IN CLINICAL DIAGNOSTIC METHODS 57
6.1.3 DEVELOPMENT IN DATABASE MANAGEMENT TOOLS AND WIDE ACCEPTANCE OF POINT-OF-CARE (POC) TESTING SOLUTIONS 58
6.1.4 RISE IN DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS 58
6.1.5 INCREASE IN APPLICATION OF HIGH-THROUGHPUT ASSAYS 59
6.2 RESTRAINTS 59
6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 59
6.2.2 STRICT REGULATORY POLICIES 60
6.3 OPPORTUNITIES 61
6.3.1 INCREASE IN ADOPTION OF DIGITAL PATHOLOGY PLATFORMS 61
6.3.2 RISE IN PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 62
6.3.3 INCREASE IN AWARENESS ABOUT DIAGNOSIS AND TREATMENT OF THE DISEASE 62
6.3.4 STRATEGIC INITIATIVES BY MARKET PLAYERS 63
6.4 CHALLENGES 63
6.4.1 INACCURATE RESULTS OF TESTS 63
7 EUROPE CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY 65
7.1 OVERVIEW 66
7.2 CLINICAL CHEMISTRY TESTING 69
7.2.1 ROUTINE CHEMISTRY TESTING 69
7.2.2 THERAPEUTIC DRUG MONITORING (TDM) TESTING 69
7.2.3 ENDOCRINOLOGY CHEMISTRY TESTING 70
7.2.4 SPECIALIZED CHEMISTRY TESTING 70
7.2.5 OTHER CLINICAL CHEMISTRY TESTING 70
7.3 HEMATOLOGY TESTING 70
7.3.1 ROUTINE HEMATOLOGY TESTING 70
7.3.2 SPECIALIZED HEMATOLOGY TESTING 71
7.3.3 COAGULATION TESTING 71
7.4 MICROBIOLOGY TESTING 71
7.4.1 INFECTIOUS DISEASE TESTING 71
7.4.2 TRANSPLANT DIAGNOSTIC TESTING 72
7.4.3 OTHER MICROBIOLOGY TESTING 72
7.5 IMMUNOLOGY TESTING 72
7.5.1 DRUGS OF ABUSE TESTING 72
7.5.2 OPIATES & OPIODES 73
7.5.3 MARIJUANA 73
7.5.4 HALLUCINOGENS 73
7.5.5 CENTRAL NERVOUS SYSTEM DEPRESSANTS 73
7.5.6 OTHERS 73
7.6 ANATOMIC PATHOLOGY SERVICES 73
7.6.1 CYTOLOGY TESTING 74
7.6.2 DIAGNOSTIC SURGICAL PATHOLOGY TESTING 74
7.6.3 AUTOPSY PATHOLOGY 74
7.6.4 CLINICAL PATHOLOGY CONSULTATIVE SERVICES 74
7.6.5 OTHERS 74
7.7 GENETIC TESTING 75
7.7.1 CHROMOSOMAL STUDIES 75
7.7.2 DNA STUDIES AND BIOCHEMICAL GENETIC STUDIES 75
7.7.3 OTHERS 75
7.8 OTHER ESOTERIC TESTING 75
8 EUROPE CLINICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY 77
8.1 OVERVIEW 78
8.2 REAL-TIME PCR 81
8.3 CHEMILUMINESCENCE IMMUNOASSAY 81
8.4 MASS SPECTROMETRY 81
8.5 ENZYME-LINKED IMMUNOSORBENT ASSAY 82
8.6 DNA SEQUENCING 82
8.7 FLOW CYTOMETRY 83
8.8 OTHER TECHNOLOGIES 83
9 EUROPE CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER 84
9.1 OVERVIEW 85
9.2 HOSPITAL-BASED LABORATORIES 88
9.3 CLINIC-BASED LABORATORIES 88
9.4 INDEPENDENT & REFERENCE LABORATORIES 88
9.5 NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES 89
10 EUROPE CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION 90
10.1 OVERVIEW 91
10.2 BIOANALYTICAL & LAB CHEMISTRY SERVICES 94
10.3 DRUG DISCOVERY AND DEVELOPMENT RELATED SERVICES 94
10.4 TOXICOLOGY TESTING SERVICES 94
10.5 CELL & GENE THERAPY RELATED SERVICES 95
10.6 PRECLINICAL & CLINICAL TRIAL RELATED SERVICES 95
10.7 OTHER CLINICAL LABORATORY SERVICES 95
11 EUROPE CLINICAL LABORATORY SERVICES MARKET, BY END USER 96
11.1 OVERVIEW 97
11.2 HOSPITALS 100
11.3 CLINICS 100
11.4 RESEARCH CENTERS 100
11.5 OTHERS 100
12 EUROPE CLINICAL LABORATORY SERVICES MARKET 101
12.1 GERMANY 106
12.2 FRANCE 110
12.3 U.K. 114
12.4 ITALY 118
12.5 SPAIN 122
12.6 RUSSIA 126
12.7 TURKEY 130
12.8 BELGIUM 134
12.9 NETHERLANDS 138
12.10 SWITZERLAND 142
12.11 REST OF EUROPE 146
13 EUROPE CLINICAL LABORATORY SERVICES MARKET, COMPANY LANDSCAPE 147
13.1 COMPANY SHARE ANALYSIS: EUROPE 147
14 SWOT ANALYSIS 148
15 COMPANY PROFILES 149
15.1 ABBOTT 149
15.1.1 COMPANY SNAPSHOT 149
15.1.2 REVENUE ANALYSIS 149
15.1.3 PRODUCT PORTFOLIO 150
15.1.4 RECENT DEVELOPMENTS 150
15.2 QUEST DIAGNOSTICS INCORPORATED 152
15.2.1 COMPANY SNAPSHOT 152
15.2.2 REVENUE ANALYSIS 153
15.2.3 SERVICE PORTFOLIO 153
15.2.4 RECENT DEVELOPMENTS 154
15.3 SYNLAB INTERNATIONAL GMBH (A SUBSIDIARY OF SYNLAB AG) 155
15.3.1 COMPANY SNAPSHOT 155
15.3.2 REVENUE ANALYSIS 155
15.3.3 SERVICE PORTFOLIO 156
15.3.4 RECENT DEVELOPMENTS 156
15.4 EUROFINS SCIENTIFIC 158
15.4.1 COMPANY SNAPSHOT 158
15.4.2 REVENUE ANALYSIS 159
15.4.3 SERVICE PORTFOLIO 159
15.4.4 RECENT DEVELOPMENTS 159
15.5 SONIC HEALTHCARE 161
15.5.1 COMPANY SNAPSHOT 161
15.5.2 REVENUE ANALYSIS 161
15.5.3 SERVICE PORTFOLIO 162
15.5.4 RECENT DEVELOPMENTS 162
15.6 ACM GLOBAL LABORATORIES 163
15.6.1 COMPANY SNAPSHOT 163
15.6.2 SERVICE PORTFOLIO 163
15.6.3 RECENT DEVELOPMENTS 164
15.7 AMEDES HOLDING GMBH 165
15.7.1 COMPANY SNAPSHOT 165
15.7.2 SERVICE PORTFOLIO 165
15.7.3 RECENT DEVELOPMENT 166
15.8 ARUP LABORATORIES 167
15.8.1 COMPANY SNAPSHOT 167
15.8.2 SERVICE PORTFOLIO 167
15.8.3 RECENT DEVELOPMENTS 168
15.9 BIOREFERENCE LABORATORIES, INC. (A SUBSIDIARY OF OPKO HEALTH, INC.) 169
15.9.1 COMPANY SNAPSHOT 169
15.9.2 REVENUE ANALYSIS 169
15.9.3 SERVICE PORTFOLIO 170
15.9.4 RECENT DEVELOPMENTS 170
15.10 CERBA HEALTHCARE 171
15.10.1 COMPANY SNAPSHOT 171
15.10.2 PRODUCT PORTFOLIO 171
15.10.3 RECENT DEVELOPMENT 171
15.11 CHARLES RIVER 172
15.11.1 COMPANY SNAPSHOT 172
15.11.2 REVENUE ANALYSIS 172
15.11.3 SERVICE PORTFOLIO 173
15.11.4 RECENT DEVELOPMENTS 174
15.12 DAVITA INC. 175
15.12.1 COMPANY SNAPSHOT 175
15.12.2 REVENUE ANALYSIS 175
15.12.3 SERVICE PORTFOLIO 176
15.12.4 RECENT DEVELOPMENTS 176
15.13 H.U. GROUP HOLDINGS, INC. 177
15.13.1 COMPANY SNAPSHOT 177
15.13.2 REVENUE ANALYSIS 177
15.13.3 SERVICE PORTFOLIO 178
15.13.4 RECENT DEVELOPMENTS 178
15.14 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 179
15.14.1 COMPANY SNAPSHOT 179
15.14.2 SERVICE PORTFOLIO 179
15.14.3 RECENT DEVELOPMENTS 184
15.15 NEOGENOMICS LABORATORIES, INC. 185
15.15.1 COMPANY SNAPSHOT 185
15.15.2 REVENUE ANALYSIS 185
15.15.3 SERVICE PORTFOLIO 186
15.15.4 RECENT DEVELOPMENTS 186
15.16 Q2 SOLUTIONS 187
15.16.1 COMPANY SNAPSHOT 187
15.16.2 PRODUCT PORTFOLIO 187
15.16.3 RECENT DEVELOPMENTS 187
15.17 UNILABS 188
15.17.1 COMPANY SNAPSHOT 188
15.17.2 SERVICE PORTFOLIO 188
15.17.3 RECENT DEVELOPMENTS 189
15.18 VIROCLINICS 190
15.18.1 COMPANY SNAPSHOT 190
15.18.2 PRODUCT PORTFOLIO 190
15.18.3 RECENT DEVELOPMENT 190
16 QUESTIONNAIRE 191
17 RELATED REPORTS 195

ページTOPに戻る

図表リスト

LIST OF TABLES
TABLE 1 DATE AND REGULATORY APPROVED THERAPEUTIC INDICATIONS FOR SINGLE-ADMINISTRATION GENE THERAPIES MARKETED IN EUROPE BETWEEN 2016 AND 2020. 43
TABLE 2 EXAMPLE OF INNOVATIVE REIMBURSEMENT MECHANISMS USED FOR GENE THERAPIES IN FRANCE: 44
TABLE 3 EXAMPLES OF INNOVATIVE REIMBURSEMENT MECHANISMS USED FOR GENE THERAPIES IN GERMANY: 45
TABLE 4 EXAMPLES OF INNOVATIVE REIMBURSEMENT MECHANISMS USED FOR GENE THERAPIES IN ITALY: 46
TABLE 5 EXAMPLES OF INNOVATIVE REIMBURSEMENT MECHANISMS USED FOR GENE THERAPIES IN SPAIN: 47
TABLE 6 EXAMPLES OF INNOVATIVE REIMBURSEMENT MECHANISMS USED FOR GENE THERAPIES IN ENGLAND: 47
TABLE 7 CLINICAL LABORATORY SERVICES IN EUROPE 54
TABLE 8 NUMBER OF CORONAVIRUS (COVID-19) TESTS PERFORMED IN THE MOST IMPACTED COUNTRIES IN THE REGION AS OF JULY 27, 2021 62
TABLE 9 TYPES AND RATES OF ERROR IN THE 3 STAGES OF THE LABORATORY TESTING PROCESS 64
TABLE 10 EUROPE CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 68
TABLE 11 EUROPE CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 69
TABLE 12 EUROPE HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 70
TABLE 13 EUROPE MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 71
TABLE 14 EUROPE DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 73
TABLE 15 EUROPE ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 74
TABLE 16 EUROPE GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 75
TABLE 17 EUROPE CLINICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 80
TABLE 18 EUROPE CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2021-2030 (USD MILLION) 87
TABLE 19 EUROPE CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 93
TABLE 20 EUROPE CLINICAL LABORATORY SERVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 99
TABLE 21 EUROPE CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 105
TABLE 22 GERMANY CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 106
TABLE 23 GERMANY CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 106
TABLE 24 GERMANY HAEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 107
TABLE 25 GERMANY MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 107
TABLE 26 GERMANY DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 107
TABLE 27 GERMANY ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 108
TABLE 28 GERMANY GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 108
TABLE 29 GERMANY CLINICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 108
TABLE 30 GERMANY CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2021-2030 (USD MILLION) 109
TABLE 31 GERMANY CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 109
TABLE 32 GERMANY CLINICAL LABORATORY SERVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 109
TABLE 33 FRANCE CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 110
TABLE 34 FRANCE CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 110
TABLE 35 FRANCE HAEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 111
TABLE 36 FRANCE MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 111
TABLE 37 FRANCE DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 111
TABLE 38 FRANCE ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 112
TABLE 39 FRANCE GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 112
TABLE 40 FRANCE CLINICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 112
TABLE 41 FRANCE CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2021-2030 (USD MILLION) 113
TABLE 42 FRANCE CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 113
TABLE 43 FRANCE CLINICAL LABORATORY SERVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 113
TABLE 44 U.K. CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 114
TABLE 45 U.K. CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 114
TABLE 46 U.K. HAEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 114
TABLE 47 U.K. MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 115
TABLE 48 U.K. DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 115
TABLE 49 U.K. ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 115
TABLE 50 U.K. GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 116
TABLE 51 U.K. CLINICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 116
TABLE 52 U.K. CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2021-2030 (USD MILLION) 116
TABLE 53 U.K. CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 117
TABLE 54 U.K. CLINICAL LABORATORY SERVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 117
TABLE 55 ITALY CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 118
TABLE 56 ITALY CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 118
TABLE 57 ITALY HAEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 118
TABLE 58 ITALY MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 119
TABLE 59 ITALY DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 119
TABLE 60 ITALY ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 119
TABLE 61 ITALY GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 120
TABLE 62 ITALY CLINICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 120
TABLE 63 ITALY CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2021-2030 (USD MILLION) 120
TABLE 64 ITALY CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 121
TABLE 65 ITALY CLINICAL LABORATORY SERVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 121
TABLE 66 SPAIN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 122
TABLE 67 SPAIN CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 122
TABLE 68 SPAIN HAEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 122
TABLE 69 SPAIN MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 123
TABLE 70 SPAIN DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 123
TABLE 71 SPAIN ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 123
TABLE 72 SPAIN GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 124
TABLE 73 SPAIN CLINICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 124
TABLE 74 SPAIN CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2021-2030 (USD MILLION) 124
TABLE 75 SPAIN CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 125
TABLE 76 SPAIN CLINICAL LABORATORY SERVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 125
TABLE 77 RUSSIA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 126
TABLE 78 RUSSIA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 126
TABLE 79 RUSSIA HAEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 127
TABLE 80 RUSSIA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 127
TABLE 81 RUSSIA DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 127
TABLE 82 RUSSIA ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 128
TABLE 83 RUSSIA GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 128
TABLE 84 RUSSIA CLINICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 128
TABLE 85 RUSSIA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2021-2030 (USD MILLION) 129
TABLE 86 RUSSIA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 129
TABLE 87 RUSSIA CLINICAL LABORATORY SERVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 129
TABLE 88 TURKEY CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 130
TABLE 89 TURKEY CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 130
TABLE 90 TURKEY HAEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 131
TABLE 91 TURKEY MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 131
TABLE 92 TURKEY DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 131
TABLE 93 TURKEY ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 132
TABLE 94 TURKEY GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 132
TABLE 95 TURKEY CLINICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 132
TABLE 96 TURKEY CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2021-2030 (USD MILLION) 133
TABLE 97 TURKEY CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 133
TABLE 98 TURKEY CLINICAL LABORATORY SERVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 133
TABLE 99 BELGIUM CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 134
TABLE 100 BELGIUM CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 134
TABLE 101 BELGIUM HAEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 135
TABLE 102 BELGIUM MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 135
TABLE 103 BELGIUM DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 135
TABLE 104 BELGIUM ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 136
TABLE 105 BELGIUM GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 136
TABLE 106 BELGIUM CLINICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 136
TABLE 107 BELGIUM CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2021-2030 (USD MILLION) 137
TABLE 108 BELGIUM CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 137
TABLE 109 BELGIUM CLINICAL LABORATORY SERVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 137
TABLE 110 NETHERLANDS CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 138
TABLE 111 NETHERLANDS CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 138
TABLE 112 NETHERLANDS HAEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 139
TABLE 113 NETHERLANDS MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 139
TABLE 114 NETHERLANDS DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 139
TABLE 115 NETHERLANDS ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 140
TABLE 116 NETHERLANDS GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 140
TABLE 117 NETHERLANDS CLINICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 140
TABLE 118 NETHERLANDS CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2021-2030 (USD MILLION) 141
TABLE 119 NETHERLANDS CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 141
TABLE 120 NETHERLANDS CLINICAL LABORATORY SERVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 141
TABLE 121 SWITZERLAND CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 142
TABLE 122 SWITZERLAND CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 142
TABLE 123 SWITZERLAND HAEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 143
TABLE 124 SWITZERLAND MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 143
TABLE 125 SWITZERLAND DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 143
TABLE 126 SWITZERLAND ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 144
TABLE 127 SWITZERLAND GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 144
TABLE 128 SWITZERLAND CLINICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 144
TABLE 129 SWITZERLAND CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2021-2030 (USD MILLION) 145
TABLE 130 SWITZERLAND CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 145
TABLE 131 SWITZERLAND CLINICAL LABORATORY SERVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 145
TABLE 132 REST OF EUROPE CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2021-2030 (USD MILLION) 146